{"id":"https://openalex.org/W169735239","doi":null,"title":"Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study.","display_name":"Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study.","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W169735239","mag":"169735239","pmid":"https://pubmed.ncbi.nlm.nih.gov/12073765"},"language":"en","primary_location":{"id":"pmid:12073765","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12073765","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs under experimental and clinical research","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"F Castellano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152331","display_name":"IBSA Institut Biochimique (Switzerland)","ror":"https://ror.org/051tj3a26","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210152331"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"F Castellano","raw_affiliation_strings":["IBSA Institut Biochimique S.A., 6915 Pambio-Noranco, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IBSA Institut Biochimique S.A., 6915 Pambio-Noranco, Switzerland","institution_ids":["https://openalex.org/I4210152331"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055343941","display_name":"Giuseppe Mautone","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Mautone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.138,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.76219105,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"28","issue":"1","first_page":"27","last_page":"35"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10984","display_name":"Sinusitis and nasal conditions","score":0.40799999237060547,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10984","display_name":"Sinusitis and nasal conditions","score":0.40799999237060547,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.30320000648498535,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11812","display_name":"Nasal Surgery and Airway Studies","score":0.13609999418258667,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/xylometazoline","display_name":"xylometazoline","score":0.9950000047683716},{"id":"https://openalex.org/keywords/nasal-spray","display_name":"nasal spray","score":0.8730000257492065},{"id":"https://openalex.org/keywords/hyaluronic-acid","display_name":"hyaluronic acid","score":0.9589999914169312},{"id":"https://openalex.org/keywords/nasal-congestion","display_name":"nasal congestion","score":0.8479999899864197},{"id":"https://openalex.org/keywords/nasal-resistance","display_name":"nasal resistance","score":0.6359999775886536},{"id":"https://openalex.org/keywords/imidazoline-derivatives","display_name":"imidazoline derivatives","score":0.6980000138282776},{"id":"https://openalex.org/keywords/preservative-free-formulation","display_name":"preservative-free formulation","score":0.6990000009536743},{"id":"https://openalex.org/keywords/benzalkonium-chloride","display_name":"benzalkonium chloride","score":0.902999997138977},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.6620000004768372},{"id":"https://openalex.org/keywords/intranasal-drug-delivery","display_name":"intranasal drug delivery","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6435657739639282},{"id":"https://openalex.org/C2910477827","wikidata":"https://www.wikidata.org/wiki/Q430719","display_name":"Nasal decongestant","level":2,"score":0.6076458692550659},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5151132941246033},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5129982829093933},{"id":"https://openalex.org/C2778385066","wikidata":"https://www.wikidata.org/wiki/Q430719","display_name":"Decongestant","level":3,"score":0.47894173860549927},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.42582768201828003},{"id":"https://openalex.org/C2776880894","wikidata":"https://www.wikidata.org/wiki/Q324089","display_name":"Antihistamine","level":2,"score":0.09654712677001953}],"mesh":[{"descriptor_ui":"D000281","descriptor_name":"Administration, Intranasal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000403","descriptor_name":"Airway Resistance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014663","descriptor_name":"Nasal Decongestants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:12073765","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12073765","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs under experimental and clinical research","raw_type":"Clinical Trial"},{"id":"mag:169735239","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12073765","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1988825735","https://openalex.org/W2896186044","https://openalex.org/W2087550724","https://openalex.org/W2114231332","https://openalex.org/W2810418109","https://openalex.org/W1920461561","https://openalex.org/W90139055","https://openalex.org/W2048844952","https://openalex.org/W4210414457","https://openalex.org/W4237072015"],"abstract_inverted_index":{"Xylometazoline":[0],"hydrochloride":[1],"is":[2],"an":[3,224],"imidazoline":[4],"derivative":[5],"commonly":[6],"used":[7],"in":[8,65,71,115],"topical":[9],"application":[10],"to":[11,134,162,178,206,221],"relieve":[12],"nasal":[13,130],"congestion":[14],"associated":[15],"with":[16,46,91],"acute":[17],"or":[18,27],"chronic":[19],"rhinitis,":[20],"common":[21],"cold,":[22],"sinusitis":[23],"and":[24,49,61,87,103,128,212],"hay":[25],"fever":[26],"other":[28,235],"allergies.":[29],"To":[30],"reduce":[31],"the":[32,36,66,138,150,163,172,188,191,194,209,213,227],"negative":[33],"effects":[34,123],"on":[35,126],"mucosal":[37],"defensive":[38],"mechanism,":[39],"a":[40,72,92,104,142,154,167,198,241],"new":[41,67,77,139,151,164,195,238],"formulation":[42,68,78,140,152,165,196,211,239],"of":[43,59,83,124,144,156,169,175,193,200,208,216,226,243],"xylometazoline":[44,60,84,100,125,176,217],"(Rhinostop)":[45],"inactive":[47],"preservatives":[48],"hyaluronic":[50],"acid":[51],"(HA)":[52],"was":[53,89,119,146,159,202,245],"studied.":[54],"The":[55,76,112,122,237],"most":[56],"appropriate":[57],"concentration":[58,143,155,168,174,199,242],"its":[62],"decongestant":[63,181],"activity":[64],"were":[69,132,185],"investigated":[70],"double-blind,":[73],"dose-effect":[74],"study.":[75],"at":[79,141,153,166,197,240],"three":[80,95],"different":[81],"concentrations":[82],"(0.025%,":[85],"0.05%":[86,145,173,201,244],"0.1%)":[88],"compared":[90],"placebo":[93],"formulation,":[94,106],"equivalent":[96,161],"aqueous":[97,214],"solutions":[98],"containing":[99,107],"(without":[101],"HA)":[102],"reference":[105,210],"benzalkonium":[108],"chloride":[109],"as":[110,223,231],"preservative.":[111],"drugs'":[113],"efficacy":[114,192],"reducing":[116],"airflow":[117],"resistance":[118,131],"also":[120,203],"evaluated.":[121],"inspiratory":[127],"expiratory":[129],"found":[133],"be":[135],"concentration-dependent.":[136],"Indeed,":[137],"more":[147],"effective":[148],"than":[149],"0.025%,":[157],"but":[158],"statistically":[160,204],"0.1%;":[170],"therefore,":[171],"seemed":[177],"achieve":[179],"maximal":[180],"activity.":[182],"These":[183],"findings":[184],"confirmed":[186],"by":[187],"observation":[189],"that":[190,207],"comparable":[205],"solution":[215],"0.1%.":[218],"HA":[219],"seems":[220],"act":[222],"enhancer/carrier":[225],"active":[228],"principle,":[229],"xylometazoline,":[230],"already":[232],"demonstrated":[233],"for":[234,248],"drugs.":[236],"therefore":[246],"selected":[247],"further":[249],"clinical":[250],"development.":[251]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}